Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDWF.L Regulatory News (DWF)

  • There is currently no data for DWF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: DWF Group (DWF) - Investor Forum company research (Nov 2021)

2 Dec 2021 10:35

Hardman & Co Research Hardman & Co Research: DWF Group (DWF) - Investor Forum company research (Nov 2021) 02-Dec-2021 / 10:35 GMT/BST


Hardman & Co November 2021 Investor Forum company research:

DWF Group (DWF)

On 18 November we were delighted to host our final Investor Forum of the year. At the live event, the CEO of DWF Group, Chris Stefani, engaged with the audience through the Q&A, explaining in detail its corporate culture, staff retentions, the benefits of being listed on the main market versus AIM, and the key metrics differentiating DWF from its competitors.

 We would like to share with you the research note and slide pack, along with the recording of the presentation.

Read DWF research note | Download DWF |

Watch DWF forum recording

If you are interested in meeting the company, you can register your interest by clicking here.

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Paul Singer

+44 20 3693 7075

 

ps@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1253724 02-Dec-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
14th Mar 202312:08 pmRNSHolding(s) in Company
14th Feb 20237:00 amRNSDWF reappointed to RSA defence panel
2nd Feb 20234:00 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
30th Jan 20232:29 pmRNSDirectorate Change
24th Jan 20237:00 amRNSHolding(s) in Company
16th Jan 202312:22 pmRNSDirector/PDMR Shareholding
10th Jan 202312:32 pmRNSHolding(s) in Company
9th Jan 20237:00 amRNSDWF reappointed to Aviva core legal panel
3rd Jan 20231:16 pmRNSIssue of Consideration Shares &Total Voting Rights
15th Dec 202212:48 pmRNSHolding(s) in Company
9th Dec 202211:13 amRNSDirector/PDMR Shareholding
8th Dec 20229:37 amRNSDirector/PDMR Shareholding
8th Dec 20227:00 amRNSHalf Year Results
6th Dec 20227:00 amRNSDWF completes transaction with Whitelaw Twining
29th Nov 20224:36 pmRNSPrice Monitoring Extension
7th Nov 20227:00 amRNSDWF to acquire leading Canadian law firm
13th Oct 202211:42 amRNSHolding(s) in Company
4th Oct 202212:10 pmRNSDirector Declaration
28th Sep 20224:24 pmRNSResults of the Annual General Meeting
28th Sep 20227:00 amRNSAGM Statement
15th Sep 20227:00 amRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSDWF expands its Connected Services capability
6th Sep 20227:00 amRNSDWF appoints Chief Growth & Strategy Officer
31st Aug 202211:33 amRNSDirector/PDMR Shareholding
17th Aug 20224:14 pmRNSAnnual report and accounts and Notice of AGM
4th Aug 20224:00 pmRNSDirector/PDMR Shareholding
26th Jul 20224:40 pmRNSSecond Price Monitoring Extn
26th Jul 20224:35 pmRNSPrice Monitoring Extension
22nd Jul 20221:25 pmRNSDirector/PDMR Shareholding
21st Jul 20227:00 amRNSFull-year results for the year ended 30 April 2022
27th May 20227:00 amRNSAppointment of Joint Corporate Broker
26th May 20227:05 amRNSDWF agrees Hong Kong affiliation
26th May 20227:00 amRNSFY22 Trading Statement
21st Mar 20227:00 amRNSDWF announces new associations
21st Jan 202211:44 amRNSDWF Legal Services Panel Appointment
22nd Dec 202110:24 amRNSDirector Declaration
9th Dec 202110:26 amRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSHalf-year Report
9th Dec 20217:00 amRNSDWF Group plc announces global ESG Strategy
2nd Dec 202110:35 amEQSHardman & Co Research: DWF Group (DWF) - Investor Forum company research (Nov 2021)
8th Nov 20212:05 pmEQSHardman & Co Research : Hardman & Co Video Event | DWF Group plc - Investor Forum
3rd Nov 20215:07 pmEQSHardman & Co Video Event | DWF Group plc Investor Forum
28th Sep 20213:34 pmRNSResults of the Annual General Meeting
28th Sep 20217:00 amRNSAGM Trading Update and notice of results
27th Aug 20215:15 pmRNSDirector/PDMR Shareholding
24th Aug 20215:04 pmRNSAGM and other meetings
23rd Aug 202111:29 amRNSHolding(s) in Company
17th Aug 20215:17 pmRNSDirector/PDMR Shareholding
10th Aug 20217:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.